Kalderos

As we continue optimizing our products and features, and our client base climbs, our Customer Success team grows with it! We are so excited to announce Jill Bertolotti, Christina M., and Jessica Ostrander as our newest team members. Their experiences and approach will ensure that Kalderos continues to provide an unmatched level of exceptional service and engagement. Please join us in extending a warm welcome. We are thrilled to have Jill, Christina, and Jessica on the team! 🌟

Although Medicaid provides health and long-term care coverage to 1 in 5 low-income Americans, state spending on enrollees varies widely, according to a new report by KFF (formerly Kaiser Family Foundation). The report shows that per-enrollee spending on average was $7,593 in 2021, but was as low as $3,023 on average for children and as much as $18,923 for older adults. Spending also varied widely within states for the same type of enrollee. For example, the lowest-cost enrollees with a disability in Virginia cost the state as little as $16,051 to as much as $127,703 in 2021. KFF researchers attribute the range of spending, in part, to the wide flexibility states have to determine Medicaid eligibility levels, benefits and provider payments. Learn more: https://lnkd.in/g8Vi2gZX | #Medicaid #MedicaidDrugRebateProgram #MDRP #HealthcareCosts #HealthcareSpending

We are always eager to work with and learn from Sheena Soni, and this month we are thrilled to recognize her in our Employee Spotlight! 🎉 Thanks for all you do, Sheena!

👋 Say hello to our newest team members! We are thrilled to have welcomed such a bright group of talented individuals to Team K this week. Please join us in extending a warm welcome to: 🔹 Kyoung K. 🔹 Nico Medina 🔹 Cameron Moshyedi, CFA 🔹 Partha Mukherjee, M.Sc, CRCR, PMP 🔹 Ivanna Rodríguez Lobo We're excited to see how their unique skills, experiences, and perspectives help us continue to innovate and excel in our industry. We know that their contributions will play a crucial role in driving our mission forward and achieving our ambitious goals. Let's do this!

🚨 Less than 24 hours to go 🚨 Join us for a very informative webinar led by our very own CSO, Daryl Todd. Register today!

It is a great pleasure to introduce our newest team members, Erika Cardenas and Jeff McConnell! In the short time Erika and Jeff have been on our team, they've already made an immediate impact. We're thrilled to have incredibly talented individuals join us during an especially transformative time 🎉 Welcome to Team K! #BiasToAction #OneTeam #LeadByExample #DumpsterDivingDataMaven

Modern Healthcare explores the many healthcare policies, programs and regulations that could be impacted by the recent U.S. Supreme Court Chevron ruling limiting federal agencies’ authority, including the 340B Drug Pricing Program. For the overview, the publication’s staff interviewed healthcare law and policy experts, one of whom suggested that, without new legislation, the continued lawsuits and conflicting lower court rulings concerning the program may lead to the Supreme Court deciding its fate. https://lnkd.in/g3dvC_hp #340B #340BReform #Chevron #GenesisRuling #HRSA

A Missouri bill that abolishes limits on the number of pharmacies a 340B Drug Pricing Program-eligible covered entity can contract with will become law at the end of August despite the lack of the governor’s signature. The bill, SB 751, was aimed at blocking drug manufacturers from restricting which pharmacies can participate in a federal drug price discount program, according to news reports. Governor Mike Parson (R-Missouri) declined to sign or veto the bill, stating in a letter to Missouri’s Secretary of State that the legislation does meet the goal of enabling patients to access affordable drugs, but it fails to correct the many problems of the federal program, such as a lack of requirements for cost savings to be passed to patients or any transparency on how cost savings are used. Pharmaceutical manufacturer AbbVie filed a lawsuit to block the new law lessthan two weeks after its passage. https://lnkd.in/g7KQ2vmv | #340B #DrugDiscountMarket #DataTransparency #ContractPharmacies #DuplicateDiscounts

Our board member and veteran healthcare and life sciences attorney William Sarraille was a recent guest on the podcast “The RealPharma Podcast: Conversations with Pharma Pathfinders.” Podcast hosts Na-Ri Oh, MD, and Ian Wendt discuss the 340B Drug Pricing Program with Bill, who explains his concerns about the lack of transparency and accountability in the program, as well as how the program has lost its way in delivering value to patients and ensuring that they benefit from the discounts. The discussion considers the need for a more comprehensive and standardized system that ensures the benefits of the program flow to the patients. Bill also explains how implementing a unified and transparent claims management process could provide faster payment and greater certainty for both manufacturers and 340B entities. Listen to the full episode here: https://lnkd.in/g7wsHxkU | #340B #340BReform #Pharma #DrugDiscountMarket

It’s already August, which means the Kalderos webinar, “Revolutionizing Government Discount Programs: Why Traditional Methods Fail,” is coming up fast – Aug. 21, to be exact. Kalderos Chief Strategy Officer Daryl Todd will offer his insights during this webinar into how drug discount stakeholders – manufacturers, covered entities, and state Medicaid offices – can best navigate the uncertain waters surrounding 340B and other drug discount programs. Attendees will learn how technology can be leveraged to ensure drug program compliance and what needs to be done to restore mutual trust across the drug discount ecosystem. If your organization is being impacted by the exponential growth, systemic waste, and misaligned incentives undermining 340B and other drug discount programs, you can’t afford to miss this webinar. REGISTER HERE: https://lnkd.in/df_KB8fk I #340B #MedicaidDrugRebateProgram #MDRP #DrugDiscounts #InflationReductionAct